comparemela.com

Latest Breaking News On - Therapeuticsmd company profile - Page 2 : comparemela.com

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the stock. TherapeuticsMD Stock Up 0.9 % NASDAQ TXMD opened at $2.26 on Tuesday. The company has a 50 day moving average of $2.30 and a 200-day moving average of […]

StockNews com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the stock. TherapeuticsMD Stock Performance NASDAQ TXMD opened at $2.27 on Thursday. TherapeuticsMD has a 52-week low of $1.95 and a 52-week high of $5.40. The company has a 50-day […]

StockNews com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Short Interest in TherapeuticsMD, Inc (NASDAQ:TXMD) Drops By 56 8%

TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 88,700 shares, a decrease of 56.8% from the November 30th total of 205,400 shares. Based on an average trading volume of 22,700 shares, the days-to-cover ratio is presently 3.9 days. […]

TherapeuticsMD (NASDAQ:TXMD) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Saturday. The firm issued a hold rating on the stock. Separately, Cantor Fitzgerald reaffirmed a neutral rating on shares of TherapeuticsMD in a report on Thursday, August 17th. View Our Latest Stock Report on TXMD TherapeuticsMD Price Performance […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.